FDA Warning Letter — BRI Institutional Review Board, Inc.
The FDA took a Warning Letter action against BRI Institutional Review Board, Inc. on October 5, 2009 (Houston, TX). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.
Action Details
- Facility
- BRI Institutional Review Board, Inc.
- Date
- October 5, 2009
- Fiscal Year
- 2010
- Product Type
- Drugs
- Center
- CDER
- Location
- Houston, TX (United States)